Recent

% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • gladpick gladpick Nov 27, 2012 1:29 PM Flag

    GILDreport

    SVR12 was 80%. The only problem is that it was based on geno 2 and geno 3--the easier to treat group.
    Below is the government's defintion of the 3 HCV genotypes.

    Genotype 1 (more difficult to treat)
    Approximately 72% of Americans with hepatitis C have genotype 1
    Chance of clearing hepatitis C virus is 42-46%
    Treatment usually lasts for 1 year
    Ribavirin dosage usually is higher than that required to treat other genotypes

    Genotype 2 (easier to treat)
    Approximately 10% of Americans with hepatitis C have genotype 2
    Chance of clearing hepatitis C virus is 65-80%
    Treatment usually lasts for 6 months
    Ribavirin dosage usually is lower than that required to treat genotype 1

    Genotype 3 (easier to treat)
    Approximately 6% of Americans with hepatitis C have genotype 3
    Chance of clearing hepatitis C virus is 65-80%
    Treatment usually lasts for 6 months
    Ribavirin dosage usually is lower than that required to treat genotype 1

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
VRTX
120.34+2.740(+2.33%)Mar 27 4:00 PMEDT